# Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

> **NCT05164952** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Use of Zoledronic Acid in Breast Cancer

## Interventions

- **DRUG:** Zoledronic Acid 4 MG

## Key facts

- **NCT ID:** NCT05164952
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-30
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164952, "Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05164952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*